1996•The Journal of UrologyRequires access
Commentary on Genetic Prognostic Markers for Transitional Cell Carcinoma of the Bladder: From Microscopes to Molecules
Dan Theodorescu
Open publisher page 8 citations
Abstract
No AccessJournal of UrologyClinical Urology: This Month in Investigative Urology1 Jan 1996Commentary on Genetic Prognostic Markers for Transitional Cell Carcinoma of the Bladder: From Microscopes to Molecules Dan Theodorescu Dan TheodorescuDan Theodorescu More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(01)66523-6AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Commentary on Genetic Prognostic Markers for Transitional Cell Carcinoma of the Bladder: From Microscopes to Molecules." The Journal of Urology, 155(1), p. 2 References 1 : Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. J. Natl. Cancer Inst.1992; 84: 1256. Crossref, Medline, Google Scholar 2 : Accumulation of nuclear p53 and tumor progression in bladder cancer. N. Engl. J. Med.1994; 331: 1259. Google Scholar 3 : Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis. Br. J. Cancer1994; 69: 1120. Google Scholar 4 : Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder. A multivariate survival analysis. Am. J. Clin. Pathol.1994; 101: 166. Google Scholar 5 : An immunohistologic evaluation of C-erbB-2 gene product in patients with urinary bladder carcinoma. Cancer1992; 70: 2493. Crossref, Medline, Google Scholar 6 : Ha-ras induction of the invasive phenotype results in up-regulation of epidermal growth factor receptors and altered responsiveness to epidermal growth factor in human papillary transitional cell carcinoma cells. Cancer Res.1991; 51: 4486. Google Scholar 7 : Identification of p53 gene mutations in bladder cancers and urine samples. Science1991; 252: 706. Crossref, Medline, Google Scholar Division of Urologic Oncology, University of Virginia Cancer Center, Charlottesville, Virginia.© 1996FiguresReferencesRelatedDetailsCited byFILIADIS I, GEORGIOU I, ALAMANOS Y, KRANAS V, GIANNAKOPOULOS X and LOLIS D (2018) GENOTYPES OF N-ACETYLTRANSFERASE-2 AND RISK OF BLADDER CANCER: A CASE-CONTROL STUDYJournal of Urology, VOL. 161, NO. 5, (1672-1675), Online publication date: 1-May-1999.BASSI P, FERRANTE G, PIAZZA N, SPINADIN R, CARANDO R, PAPPAGALLO G and PAGANO F (2018) PROGNOSTIC FACTORS OF OUTCOME AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER: A RETROSPECTIVE STUDY OF A HOMOGENEOUS PATIENT COHORTJournal of Urology, VOL. 161, NO. 5, (1494-1497), Online publication date: 1-May-1999.Waters W (2018) Editorial: Invasive Bladder Cancer–Where Do We Go from Here?Journal of Urology, VOL. 155, NO. 6, (1910-1911), Online publication date: 1-Jun-1996. Volume 155Issue 1January 1996Page: 2 Advertisement Copyright & Permissions© 1996MetricsAuthor Information Dan Theodorescu More articles by this author Expand All Advertisement PDF downloadLoading ...